Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.
3.
4.

[Antidepressant effect of 3-oxypyridine and succinic acid derivatives (experimental study)].

Volchegorskii IA, Miroshnichenko IY, Rassokhina LM, Malkin MP, Faizullin RM, Pryakhina KE, Kalugina AV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(2):48-52. doi: 10.17116/jnevro20151152148-52. Russian.

PMID:
26081324
5.

[Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in acute phase of alloxan-induced diabetes mellitus in rats].

Volchegorskiĭ IA, Rassokhina LM, Miroshnichenko IIu.

Eksp Klin Farmakol. 2011;74(5):17-25. Russian.

PMID:
21809693
6.
7.

[Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in alloxan diabetes].

Volchegorskii LA, Miroshnichenko IY, Rassokhina LM, Faizullin RM, Pryakhina KE, Kalugina AV.

Ross Fiziol Zh Im I M Sechenova. 2015 Mar;101(3):258-67. Russian.

PMID:
26016320
8.

Comparative analysis of the anxiolytic effects of 3-hydroxypyridine and succinic acid derivatives.

Volchegorskii IA, Miroshnichenko IY, Rassokhina LM, Faizullin RM, Malkin MP, Pryakhina KE, Kalugina AV.

Bull Exp Biol Med. 2015 Apr;158(6):756-61. doi: 10.1007/s10517-015-2855-3. Epub 2015 Apr 21.

PMID:
25894772
9.

[The effect of 3-oxypyridine and succinic acid derivatives on the resistance to acute cerebral ischemia].

Volchegorskiĭ IA, Miroshnichenko II, Rassokhina LM, Faĭzullin RM, Priakhina KE, Malkin MP, Kalugina AV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(12):123-127. doi: 10.17116/jnevro2014114121123-127. Russian.

PMID:
25726791
10.

[Effectiveness of 3-hydroxypyridine and succinic acid derivatives in complex treatment of primary open-angle glaucoma].

Volchegorskiĭ IA, Tur EV, Soliannikova OV, Rykun VS, Sumina MS, Dmitrienko VN, Berdnikova EV.

Eksp Klin Farmakol. 2012;75(7):20-6. Russian.

PMID:
23025048
11.

Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes.

Volchegorskii IA, Rassokhina LM, Miroshnichenko IY.

Bull Exp Biol Med. 2013 May;155(1):56-64.

PMID:
23667872
12.

[Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].

Volchegorskiĭ IA, Rassokhina LM, Miroshnichenko IIu.

Eksp Klin Farmakol. 2011;74(12):27-32. Russian.

PMID:
22379879
13.

[The effect of 3-oxypyridine and succinic acid derivatives on obsessive-compulsive activity of mice in marble-burying test].

Volchegorskiĭ IA, Miroshnichenko IIu, Rassokhina LM, Faĭzullin RM, Priakhina KE.

Eksp Klin Farmakol. 2014;77(10):10-4. Russian.

PMID:
25518521
14.
16.

[Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in experimental diabetes mellitus].

Volchegorskiĭ IA, Rassokhina LM, Miroshnichenko IIu.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(6):50-61. Russian.

PMID:
23887452
17.
18.

[The influence of 3-oxypyridine antioxidants on depression in patients with diabetes mellitus].

Volchegorskiĭ IA, Mester NV.

Klin Med (Mosk). 2007;85(2):40-5. Russian.

PMID:
17520888
19.

[Efficacy of pathogenetic therapy in patients with acute gastrointestinal infections using succinic acid derivatives (reamberin)].

Tikhonova EO, Liapina EP, Shul'diakov AA.

Eksp Klin Farmakol. 2013;76(1):11-3. Russian.

PMID:
23461009
20.

[Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in the acute phase of alloxan-induced diabetes in rats].

Volchegorskiĭ IA, Miroshnichenko IIu, Rassokhina LM, Faĭzullin RM, Malkin MP, Priakhina KE, Kalugina AV.

Eksp Klin Farmakol. 2014;77(4):14-20. Russian.

PMID:
25076754

Supplemental Content

Support Center